Welcome to our dedicated page for Golden Matrix SEC filings (Ticker: GMGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Regulated gaming disclosures are rarely simple. Golden Matrix Group’s mix of B2B platform licensing and Meridianbet’s consumer sportsbook means each 10-K, 10-Q, or 8-K packs pages of jurisdictional rules, segment revenue notes, and technology acquisition details. Finding when a new gaming license is approved or how sportsbook margins shift quarter to quarter can feel like looking for one card in a shuffled deck.
Stock Titan answers that challenge. Our AI reads every Golden Matrix Group quarterly earnings report 10-Q filing, tags the gaming metrics that move models, and delivers plain-English summaries within minutes. Need Golden Matrix Group insider trading Form 4 transactions or alerts on Golden Matrix Group Form 4 insider transactions real-time? They appear on your dashboard as soon as EDGAR posts. We also link key questions investors search for—“understanding Golden Matrix Group SEC documents with AI” or “Golden Matrix Group annual report 10-K simplified”—directly to concise explanations, footnote callouts, and ratio trend charts.
Whether you’re tracking marketing spend that fuels new user growth, comparing sportsbook hold percentages across regions, or reviewing the Golden Matrix Group proxy statement executive compensation, this page keeps every filing type in one place with real-time updates. Explore the latest 8-K material events explained, see a side-by-side Golden Matrix Group earnings report filing analysis, and monitor Golden Matrix Group executive stock transactions Form 4 without wading through hundreds of pages. Complex gaming disclosures, clarified by AI—so you can focus on making calls, not decoding forms.
Golden Matrix Group, Inc. (Nasdaq: GMGI) filed a Rule 424(b)(5) prospectus supplement establishing an at-the-market (ATM) program that allows the company to sell up to US$13.0 million of common stock through Craig-Hallum Capital Group LLC. The supplement sits under an existing Equity Distribution Agreement that authorizes sales of up to US$20 million; to date, only 332,166 shares for US$609,376 have been issued, leaving US$19.39 million in total capacity, though Form S-3 “baby-shelf” limits reduce the immediate ceiling to US$13.0 million.
Craig-Hallum will act as sales agent or principal and is entitled to a 3.0 % commission on gross proceeds. Sales will be conducted as “at-the-market offerings” under Rule 415, with no minimum draw, escrow, or specific closing requirements, giving the company significant tactical flexibility. The shares will be offered at prevailing market prices; on 24 June 2025 GMGI last traded at US$1.75.
As of the same date, GMGI’s public float was approximately US$41.6 million (138.86 million shares outstanding, 117.95 million held by affiliates). Under General Instruction I.B.6, the company may not sell more than one-third of its public float within any 12-month period while float remains below US$75 million; after deducting prior ATM usage, this caps new issuance at roughly US$13.26 million, aligning with the size of this prospectus.
The supplement reiterates standard risk disclosures, underwriter indemnification commitments, and the absence of regulatory approval. Net proceeds will be applied as described in the “Use of Proceeds” section (not detailed here). Investors should consider potential dilution, market-pressure effects, and the “Risk Factors” referenced from GMGI’s 10-K and 10-Q filings.